Sentences with phrase «used in embryonic stem cell»

It can be used in embryonic stem cell research, or in regenerative medicine where it is sometimes referred to as «therapeutic cloning.»

Not exact matches

If we are against the use of stem cell research on the basis of embryonic destruction, shouldn't we also be against in - vitro fertilization clinics because there are always excess embryos that get discarded?

In addition, scientific journals continue to push the issue of embryonic stem - cell research in their editorial and commentary sections, using it as a prime criterion to grade political candidateIn addition, scientific journals continue to push the issue of embryonic stem - cell research in their editorial and commentary sections, using it as a prime criterion to grade political candidatein their editorial and commentary sections, using it as a prime criterion to grade political candidates.

(i) a woman's right to an abortion; (iii) medical immunization of teen girls (and boys) against HPV; (iv) assisted suicide; (vi) gay marriage; (vii) my right to view art and theatre deemed «offensive,» «blasphemous» or «obscene» Catholics; (viii) basic $ ex education for older school children; (ix) treating drug abuse as principally a medical issue; (x) population control; (xi) buying alcohol on a Sunday in many places; (xii) use of condoms and other contraceptives; (xiii) embryonic stem cell research; (xiv) little 10 year - old boys joining organizations such as the Boy Scouts of America, regardless of the religious views of their parents; and (xv) gays being allowed to serve openly in the military.

Sullivan went on to suggest that Chaput is using a double standard in the 2008 election by criticizing Catholic supporters of Barack Obama, while turning a blind eye to John McCain's support for embryonic stem cell research.

In August of last year, President Bush approved the use of federal funds to support research on a limited number of existing human embryonic stem cell lines.

The increasing use of in - vitro - fertilisation techniques, and the emergence of new possibilities involving human cloning, mixing of human and animal genetic elements, and the use of embryonic stem cells for research, among other things, brought the need for further teaching.

In a study in the journal Science, researchers explain how they used mouse embryonic stem cells and microchip technology to create heart muscle tissue that actually beatIn a study in the journal Science, researchers explain how they used mouse embryonic stem cells and microchip technology to create heart muscle tissue that actually beatin the journal Science, researchers explain how they used mouse embryonic stem cells and microchip technology to create heart muscle tissue that actually beats.

Furthermore, by making use of embryonic stem cells and in vitro differentiation, SIF - seq can be used to assess enhancer activity in a wide variety of disease - relevant cell types.»

The ability of SIF - seq to use reporter assays in mouse embryonic stem cells to identify human embryonic stem cell enhancers that are not present in the mouse genome opens the door to intriguing research possibilities as Dickel explains.

Trials of cells made from human embryonic stem cells are also poised to begin in people with type 1 diabetes and heart failure, the first time embryonic stem cells have been used in the treatment of major lethal diseases.

«We've shown that SIF - seq can be used to identify enhancers active in cardiomyocytes, neural progenitor cells, and embryonic stem cells, and we think that it has the potential to be expanded for use in a much wider variety of cell types,» Dickel says.

That includes not only procedures in which embryonic - stem - cell lines are created, but also those that use previously derived cell lines.

The study results were found using mouse embryonic stem cells, which are good cell models for the study of processes seen in human stem cells.

Advanced Cell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastocCell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastoccell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastocyst.

But the methods used to reprogram cells can damage their DNA, and the iPS cells may not behave in exactly the same way as embryonic stem cells.

Using a mathematical model known as the Ising model, invented to describe phase transitions in statistical physics, such as how a substance changes from liquid to gas, the Johns Hopkins researchers calculated the probability distribution of methylation along the genome in several different human cell types, including normal and cancerous colon, lung and liver cells, as well as brain, skin, blood and embryonic stem cells.

Existing European patents involving embryonic stem cells — most of which were issued in the United Kingdom — will not be invalidated immediately, but lawsuits challenging individual patents will use the ruling as guidance.

Research involving the derivation and use of embryonic stem (ES) cells is permissible only where there is strong scientific merit in, and potential medical benefit from, such research.

In addition, where cells derived from embryonic stem cells are great at proliferating — a potentially critical feature if one wants to grow sufficient numbers of cells for clinical use — ones from the iPS lines were much feebler.

The creation of the Centre of Regenerative Medicine in Barcelona (CMRB) reflects «a change in the Spanish public policy regarding derivation and use of human embryonic stem cells (HESC), based on a progressive evolution of the public awareness and sensibility of the Spanish [citizenry],» says CMRB Director Juan Carlos Izpisúa Belmonte in an e-mail.

It has been recognized in the scientific community that the use of embryonic stem cells in research will become more and more important.

The act of reprogramming cells to make them as capable as ones from embryos apparently can result in aberrant cells that age and die abnormally, suggesting there is a long way to go to prove such cells are really like embryonic stem cells and can find use in therapies.

ERRORS have occurred in a type of stem cell that could be used instead of embryonic stem cells — and in tissues made from them.

Then, a team led by Robert Lanza, the chief scientific officer of Advanced Cell Technology Inc. in Marlborough, Massachusetts, and his colleagues published the first results ever of a clinical trial using human embryonic stem cells.

But a number of the invited speakers, including Alan Trounson, president of the California Institute for Regenerative Medicine in San Francisco, and keynote speaker George Daley, a stem - cell scientist at Children's Hospital Boston in Massachusetts, are involved in research using human embryonic stem cells, which the Catholic Church considers unethical.

The team used human embryonic stem cells — which can transform into any cell of the body — and cultured them in a mixture of chemicals to grow human brain cells.

In May 2013, Mitalipov was the first scientist in the world to demonstrate the successful use of somatic cell nuclear transfer, or SCNT, to produce human embryonic stem cells from an individual's skin celIn May 2013, Mitalipov was the first scientist in the world to demonstrate the successful use of somatic cell nuclear transfer, or SCNT, to produce human embryonic stem cells from an individual's skin celin the world to demonstrate the successful use of somatic cell nuclear transfer, or SCNT, to produce human embryonic stem cells from an individual's skin cell.

The immediate payoff was a commercialization deal in age - related macular degeneration in which Pfizer became the first big pharma company to make a move into the use of embryonic stem cells as the basis for a tissue regeneration therapy.

Another approach to regrowing the hair cells is to use embryonic stem cells, with research in this area led by Stefan Heller and colleagues at the Massachusetts Eye and Ear Infirmary in Boston, US.

The research team used mass spectrometry to compare phosphorylation of proteins from mouse embryonic stem cells with fully functioning GSK - 3 to cells in which the gene encoding GSK - 3 had been deleted.

The laboratory process, described in the journal Scientific Reports, entails genetically modifying a line of human embryonic stem cells to become fluorescent upon their differentiation to retinal ganglion cells, and then using that cell line for development of new differentiation methods and characterization of the resulting cells.

In this way they act like embryonic stem cells and share their revolutionary therapeutic potential — and as such, they could eliminate the need for using and then destroying human embryos.

In addition to providing an alternative to embryonic stem cells for potential use in regenerating diseased tissues, iPS cells are being used to learn more about diseases, especially diseases driven by mutated geneIn addition to providing an alternative to embryonic stem cells for potential use in regenerating diseased tissues, iPS cells are being used to learn more about diseases, especially diseases driven by mutated genein regenerating diseased tissues, iPS cells are being used to learn more about diseases, especially diseases driven by mutated genes.

Starting in the mid-2000s, Yoshiki Sasai's team at the RIKEN Center for Developmental Biology in Kobe, Japan, demonstrated how to grow brainlike structures using embryonic stem cells, first from mice and then humans.

Using a nuclear protein expressed in follicle stem cells (FSCs), the researchers found that castor, which plays an important role in specifying which types of brain cells are produced during embryonic development, also helps maintain FSCs throughout the life of the animal.

Stem cell advocates have been expressing serious worry that ethical requirements spelled out in the draft guidelines — in particular, informed consent procedures for embryo donors — will rule out the use of many existing human embryonic stem cell lines, including the 21 lines approved under the Bush AdministratStem cell advocates have been expressing serious worry that ethical requirements spelled out in the draft guidelines — in particular, informed consent procedures for embryo donors — will rule out the use of many existing human embryonic stem cell lines, including the 21 lines approved under the Bush Administratstem cell lines, including the 21 lines approved under the Bush Administration.

The final guidelines on research with human embryonic stem cells issued on Monday by the National Institutes of Health set out criteria for determining which ES cell lines can be used in federally funded experiments and give NIH discretion to approve old lines that don't meet stringent modern ethical requirements.

Last January, the House of Representatives voted, 253 to 174, to pass a bill, H.R. 3, that would allow researchers to use leftover embryos from in vitro fertilization (IVF) clinics to create new lines of embryonic stem cells, and in April, the Senate passed its version of the bill.

In the past few weeks, the debate about genetic research in Germany has focused on the issue of the use of embryonic stem cells for researcIn the past few weeks, the debate about genetic research in Germany has focused on the issue of the use of embryonic stem cells for researcin Germany has focused on the issue of the use of embryonic stem cells for research.

An embryonic stem cell - derived retinal cell therapy is an attractive option because they can be used to regrow the retina cells that are lost in both diseases.

In its white paper on stem cell research published last Thursday, the DFG's senate confirmed its position that the use of adult stem cells has to have priority over embryonic stem cells.

Last May in Nature Neuroscience, his lab and a team at Columbia University reported that embryonic stem cells could be used to shed light on the origins of amyotrophic lateral sclerosis (ALS), the progressive neurodegenerative disease in which motor neurons in the brain die.

«Use of induced pluripotent stem cell (iPSC) technology» — which involves taking skin cells from patients and reprogramming them into embryonic - like stem cells capable of turning into other specific cell types relevant for studying a particular disease — «makes it possible to model dementias that affect people later in life,» says senior study author Catherine Verfaillie of KU Leuven.

Lanza previously led a clinical trial in the United States — published November 2014 in the Lancet — that demonstrated embryonic stem cells could be used safely for patients with degenerative eye diseases, but the patient sample was Caucasian with the exception of one African - American.

Ottmar Wiestler and Oliver Brüstle intend to grow neural transplantation cells using human embryonic stem cells, in a project that has been scientifically approved.

Many scientists argue that so - called research cloning, in which cloned human embryos might be used to produce embryonic stem (ES) cells, could be a boon to medicine.

The world's first chimeric monkeys were created in a laboratory last year, and they offer surprising new insights into embryonic stem cell therapy: One reason for often - poor treatment outcomes may be that we're using embryos that are, strangely, just too old.

In August of last year, President George W. Bush announced that scientists who received public research money could use only the human embryonic stem - cell lines that already exist — a decision that dismayed many researchers.

In March, President Barack Obama lifted Bush's ban on using federal funds for research on human embryonic stem cells derived after August 2001.